Foghorn Therapeutics Inc. (FHTX) income statement
FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.79−0.04 (-2.19%)
Close on Nov 18, 2026Market cap $106.30MP/E –Yield –
Foghorn Therapeutics Inc. financial ratios
See a number that looks wrong?